CRNX

#1434
Crinetics Pharmaceuticals, Inc.
40.1100 USD
+3.75%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
39.9500
40.1700
Rango anual
33.1000
57.9900
Cambio diario
+3.75%
Variación mensual
+6.93%
Variación en los últimos 6 meses
-2.41%
Cambio anual
-2.41%
Cierres anteriores
38.6600
Abrir
40.0900
Bid
Ask
Mínimo
39.9500
High
40.1700
Volumen
102
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 4.1997 B
  • Employee 594
  • Founded 2008
  • CEO N/A
  • Website www.crinetics.com
  • Headquarter Delaware, United States
  • FIGI BBG00BC59224
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.4
Relación precio/flujo de caja
568.91

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

Noticias